Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome

被引：0
|
作者：
Ignatova, G. [1 ]
Blinova, E. [1 ]
机构：
[1] South Ural State Med Univ, Therapy, Chelyabinsk, Russia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3322
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of roflumilast, novel phosphodiesterase-4 inhibitor, on lung chronic graft-versus-host disease in mice
    Kim, Sei Won
    Lim, Ji Young
    Rhee, Chin Kook
    Kim, Ji Hye
    Park, Chan Kwon
    Kim, Tae Jung
    Cho, Chul Soo
    Min, Chang Ki
    Yoon, Hyoung Kyu
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (05) : 332 - 341
  • [22] Phosphodiesterase-4 Inhibitor Roflumilast Attenuates Pulmonary Air Emboli-Induced Lung Injury
    Peng, Chung-Kan
    Huang, Kun-Lun
    Wu, Chin-Pyng
    Wu, Yao-Kuang
    Tzeng, I-Shiang
    Lan, Chou-Chin
    JOURNAL OF SURGICAL RESEARCH, 2019, 241 : 24 - 30
  • [23] Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD)
    Grootendorst, DC
    Gauw, SA
    Benschop, N
    Sterk, PJ
    Hiemstra, PS
    Rabe, KF
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2003, 16 (06) : 341 - 347
  • [24] The metabolic syndrome in patients with chronic obstructive pulmonary disease
    Ameen, Neveen Mahmoud
    Mohamed, Randa Salah El Deen
    Abd El Mageed, Nabila Ibrahim
    Abd El Wahab, Mohamed Hussein
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (03): : 593 - 596
  • [25] Metabolic syndrome in patients with chronic obstructive pulmonary disease
    Ahmed, Mahmoud El Saeed
    Abd Elnaby, Houssam Eldin Hassanin
    Hussein, Mostafa A. Roshdy
    Abo-Ghabsha, Mohammad E.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (02): : 316 - 322
  • [26] The metabolic syndrome in patients with chronic obstructive pulmonary disease
    Daouud, Abdul-Ahad
    Khoury, Abdalla
    Shakerdi, Louai
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [27] Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats
    Izikki, Mohamed
    Raffestin, Bernadette
    Klar, Juergen
    Hatzelmann, Armin
    Marx, Degenhard
    Tenor, Hermann
    Zadigue, Patricia
    Adnot, Serge
    Eddahibi, Saadia
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 54 - 62
  • [28] Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses
    Lavoie, JP
    Pasloske, K
    Joubert, P
    Cordeau, ME
    Mancini, J
    Girard, Y
    Friesen, RW
    Frenette, R
    Blouin, M
    Young, RN
    Hickey, G
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2006, 20 (01): : 175 - 181
  • [29] The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia
    Barreiro, Esther
    Puig-Vilanova, Ester
    Salazar-Degracia, Anna
    Pascual-Guardia, Sergi
    Casadevall, Carme
    Gea, Joaquim
    JOURNAL OF APPLIED PHYSIOLOGY, 2018, 125 (02) : 287 - 303
  • [30] Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease
    Govoni, Mirco
    Bassi, Michele
    Santoro, Debora
    Donegan, Sinead
    Singh, Dave
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (05) : 559 - 569
12345